Eden Hall >> JRSIS Have Submitted Prospectus to SEC

JRSIS Health Care Corporation

           have submitted prospectus to SEC


March 2014 | byEden Hall Global Capital Co., Ltd


JRSIS Health Care Corporation have submitted its much anticipated prospectus to the U.S. Securities and Exchange Commission (the “SEC”), seeking to raise $4,580,000 via the public offering of 8,000,000 shares.

For more detailed information about exact institutions, please refer to the following website:

SEC website:http://www.sec.gov/Archives/edgar/data/1597892/000114420414013680/v370774_s1.htm

JRSIS investor website: www.jhcc.cn

As a holding company, JRSIS Health Care Corporation relies on Jiarun Hospital to conduct 100% of the businesses and operations. For the year end December 31, 2012, we have generated revenues of $3,481,100, with assets of $1,614,754 as of December 31, 2012, and we have generated net income of $1,145,094. For the year end of December 31, 2013, we have generated revenues of $4,351,236, with assets of $18,519,798, and we have gene rated net income of $1,322,692.

 

On a three years basis, JRSIS’s revenue has been growing at a compound rate of approximately 28.00% annually and the Hospital anticipates this trend will remains in the high double digits as long as JRSIS’s facility operates at current level of patient and services efficiency. However, accounting for the fact that the hospital is working close to its maximum capacity, this growth trend may only extend for only 2 years unless physical capacity of the hospital is increased. In consideration of this future growth cap, the management of JRSIS is building a new medical facility in the heart of Harbin city that will be 26storeys high and contain over 500 open beds and 10-15 operation rooms. The hospital completed construction in November 2013. It is now in the process of being decorated, having regard to both patient comfort and aesthetics and our responsibility to provide comfortable staff work environments. Action is also underway to review and purchase modern medical equipment to ensure that the hospital can provide a very high standard of patient care. This process is anticipated for completion in 2014 Q3, at which time the new hospital will become the largest medical facility (both private and public) in the municipality. Expansion and growth: New building operation start from the third quarter of 2014 (all figures here are estimated)


Before

Expansion

Post

Expansion

Comparison

Increased

Comparison

%

Operation spaces square meters

3,200

24,030

20,830

651%

Beds providing

150 500 500

233%

Medical staff

160 320 320

100%

Admin staff

36 72 36 100%

Sales

$5,163,467

$10,326,934

5,163,467

100%

Profit

$1,569,595

$3,139,190

$1,569,595

100%

Total assets

$3,172,925

$22,074,131

$18,901,206

596%


Based on USA capital platform and China looks for boost its healthcare industry, we have plans to acquire similar sized hospitals in second tier cities throughout China. With more than 30 years working and business experience in health and medical services industry, management believes that we have strong opportunities to acquire other similar and/or smaller size hospitals in second tier cities throughout China.

 

JRSIS chairman Mr. Zhang said in a statement that the business had undergone “significant expansion” over the past year. “With the expansion initiatives largely implemented, management put in place a comprehensive strategy and plan focusing on key business initiatives which provide a strong platform for growth and the further development of our business,” he said.

 

It predicts that net-profit is forecast to grow to $3.22 million in FY2014 from $1.32 million in FY2013. Such expansion will be achieved through both operation of our new hospital plus acquisition of one medicine trading company and one medicine retail company owned by Mr. Zhang. 

Presentation Materials (Tap to open)

-     JRSIS Presentation CN

-     JRSIS Presentation ENG

-     JRSIS Executive Summary

-     JRSIPRE-IPO Subscription Process

-     List Of Shareholders

-     Q&A 

More information please contact: mary20116688@163.com

Mary 

Managing Partner

Eden Hall Global Capital Co., Ltd.

TEL: 86-135.1001.6379.

Mary20116688@163.com

 

Copyright © 2013
Eden Hall Global Capital Co., Ltd. , All Rights Reserved
Tel: 86-135.1001.6379. Email: mary20116688@163.com Skype: marymary4098
Office address: Unit B&C 20/F Full Win Commercial Centre,573 Nathan Road,Yau matei,Kowloon,Hong Kong